The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Peter Sleight

CV Medicine

John Radcliffe Hospital

Oxford

UK

[email]@attglobal.net

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • CV Medicine, John Radcliffe Hospital, Oxford, UK. 2009
  • Department of Cardiovascular Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK. 2001 - 2009
  • Cardiac Department, John Radcliffe Hospital, Headington, Oxford OX3 9DU, UK. 2006

References

  1. Prognostic value of blood pressure in patients with high vascular risk in the Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial study. Sleight, P., Redon, J., Verdecchia, P., Mancia, G., Gao, P., Fagard, R., Schumacher, H., Weber, M., Böhm, M., Williams, B., Pogue, J., Koon, T., Yusuf, S. J. Hypertens. (2009) [Pubmed]
  2. Clinical evidence from ONTARGET: the value of an angiotensin II receptor blocker and an angiotensin-converting enzyme inhibitor. Sleight, P. J. Hypertens. Suppl (2009) [Pubmed]
  3. Benefits, challenges, and registerability of the polypill. Sleight, P., Pouleur, H., Zannad, F. Eur. Heart J. (2006) [Pubmed]
  4. Where are clinical trials going? Society and clinical trials. Sleight, P. J. Intern. Med. (2004) [Pubmed]
  5. Angiotensin II and trials of cardiovascular outcomes. Sleight, P. Am. J. Cardiol. (2002) [Pubmed]
  6. The role of angiotensin-converting enzyme inhibitors in the treatment of hypertension. Sleight, P. Curr. Cardiol. Rep (2001) [Pubmed]
  7. Blood-pressure reduction and cardiovascular risk in HOPE study. Sleight, P., Yusuf, S., Pogue, J., Tsuyuki, R., Diaz, R., Probstfield, J. Lancet (2001) [Pubmed]
 
WikiGenes - Universities